Gabarol CR 165 Extended Releas Cr Tablet

About Gabarol CR 165 Extended Releas Cr Tablet

Gabarol CR 165 Extended Release is a tablet containing pregabalin, used for certain nerve pain and some seizure disorders. It is a prescription medicine, and the doctor decides the dose and course.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Gabarol CR 165 Extended Releas Cr Tablet?

Gabarol CR 165 Extended Release is a tablet form of pregabalin, a medicine used in adults for nerve pain from diabetes or after shingles, and for fibromyalgia or spinal cord injury nerve pain. It is also used alongside other medicines for partial-onset seizures. The extended-release tablet is taken once daily, but the doctor sets the dose and how long it is taken. Common side effects include dizziness and sleepiness, so care is needed with driving or machinery until you know how it affects you. Do not stop it suddenly without medical advice.

Uses of Gabarol CR 165 Extended Releas

Gabarol CR 165 Extended Release is used for nerve pain linked to diabetes, shingles, or spinal cord injury, and for fibromyalgia. It can also be added to other treatment for partial-onset seizures. It is not a painkiller for everyday aches and is not for sudden pain. Only a doctor can decide if it suits your condition, and the dose and course are set by the doctor.

How to use Gabarol CR 165 Extended Releas

Swallow the extended-release tablet whole with water; do not crush or chew it. It is usually taken once daily, but follow the doctor's instructions exactly. The doctor decides the dose and how long you take it. Do not stop suddenly without advice, as this can cause problems. If you miss a dose, ask your pharmacist or doctor what to do rather than doubling up.

Side effects of Gabarol CR 165 Extended Releas

Common side effects include dizziness, sleepiness, dry mouth, swelling, blurred vision, weight gain, and trouble concentrating. These may affect driving or using machines, so avoid these until you know how the medicine affects you. Some people may have serious reactions such as swelling of the face or throat, trouble breathing, or mood changes. Seek medical help if you notice any of these, and tell your doctor about any side effect that bothers you.

Safety and precautions

Do not use Gabarol CR 165 Extended Release if you are allergic to pregabalin or any ingredient. There are no adequate studies in pregnancy, so pregnant women should be told of possible risks to the baby; ask your doctor before use. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour growth. Tell your doctor if you have kidney, breathing, or mental health problems, or if you take other medicines that make you sleepy. The doctor decides if it is suitable for you.

Frequently asked questions

Is Gabarol CR 165 Extended Release safe in pregnancy or breastfeeding?

There are no adequate studies in pregnant women, so the possible risks to the baby should be discussed with your doctor. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Ask your doctor before taking it if you are pregnant, planning pregnancy, or breastfeeding.

What is Gabarol CR 165 Extended Release used for and what kind of medicine is it?

It is a tablet containing pregabalin, used for certain nerve pain such as diabetic nerve pain, pain after shingles, fibromyalgia, and spinal cord injury nerve pain. It is also added to other medicines for partial-onset seizures. It is a prescription medicine, and the doctor decides if it is right for you.

How should Gabarol CR 165 Extended Release be stored?

Keep the tablets in a cool, dry place below 30°C, away from light and moisture. Keep the container out of the reach of children. Do not use it after the expiry date. Ask your pharmacist if you are unsure how to dispose of unused medicine.

Can I stop taking Gabarol CR 165 Extended Release suddenly?

No, do not stop suddenly without medical advice, as this can cause problems. The doctor will decide how to reduce or stop it safely. Always talk to your doctor or pharmacist before making any change to your treatment.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Asibalin Capsule

25 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 7.84 ৳ 8.00 2% off per unit

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 10.78 ৳ 11.00 2% off per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Asibalin Capsule

50 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Broklin Capsule

50 mg

Pregabalin

One Pharma Ltd.

৳ 12.74 ৳ 13.00 2% off per unit

Neugalin Capsule

50 mg

Pregabalin

The ACME Laboratories Ltd.

৳ 14.31 ৳ 14.6 2% off per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.